search
Back to results

EEG Microstates Across At-Risk Mental States (DEMETER)

Primary Purpose

Psychotic Disorders, Autism Spectrum Disorder, Major Depressive Disorder

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
EEG 64 channels
Polysomnography 19 electrodes
Light hypnosis
Biological sampling
Virtual reality
Voice recording
Sponsored by
Centre Hospitalier St Anne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Psychotic Disorders focused on measuring electroencephalography, at risk mental state, ultra high risk, first episode psychosis, schizophrenia, autism spectrum disorder, EEG microstates, polysomnography, sensorimotor integration, prosody, hypnosis

Eligibility Criteria

15 Years - 30 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: age between 15 and 30 years subjects meeting CAARMS criteria for stage Ia or Ib mental states at risk (for stage Ia, mild or nonspecific symptoms of psychosis or severe mood disorder, and mild functional impairment; for stage Ib, moderate symptoms below intervention threshold and moderate functional impairment) subjects meeting any DSM-5 criteria associated with a first onset of psychotic symptoms (first episode psychosis) subjects satisfying DSM-5 criteria for depressive disorder subjects meeting DSM-5 criteria for autism spectrum disorder healthy control subjects recruited from the general population Exclusion Criteria: suicidal risk severe or non-stabilized somatic and neurological disorders epilepsy head trauma IQ below 70 for healthy control subjects, a family history of psychosis is an exclusion criterion bipolar disorder obsessive-compulsive disorder substance use disorder, except for cannabis, tolerated up to 5 joints/day.

Sites / Locations

  • Centre de Recherche Clinique, Hôpital Sainte-Anne, GHU Paris Psychiatrie et NeurosciencesRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

Major depressive disorder

Autism spectrum disorder

At risk mental state

First episode psychosis

Schizophrenia

Healthy controls

Arm Description

Major depressive disorder as defined by DSM-5 classification

Autism spectrum disorder as defined by DSM-5 classification

At risk mental state as defined in the CAARMS

Any DSM-5 category associated with psychotic symptoms

Schizophrenia as defined by DSM-5 classification

Healthy controls with no history of neurodevelopmental disorder or psychotic disorder in a first degree relative

Outcomes

Primary Outcome Measures

Occurrence of EEG microstates
Average number of times a given microstate occurs per second.
Coverage of EEG microstates
Percentage of total analysis time spent in a given microstate.
Mean duration of EEG microstates
Average time during which a given microstate was present in an uninterrupted manner (after temporal smoothing).

Secondary Outcome Measures

Attention modulation
Measurement of alpha band power (in Hz)
Cortical excitability and inhibition
Measurement of mu and theta bands (in Hz)
Integration of sensory information: amplitudes
Measurement of amplitudes (in µV) of somatosensory evoked potentials
Integration of sensory information: latencies
Measurement of latencies (in msec) of somatosensory evoked potentials
Reaction time
The adaptation of the reaction time (in msec) to the button press according to the probabilistic context of congruency is examined.
Speech rate
Measurement of number of syllables/sec in the recording of the subjects
Fundamental frequency
Measurement of the fundamental frequency (in Hz)
Pitch mean
Measurement of the pitch mean (in semi-tones)
Pitch range
Measurement of the pitch range (in semi-tones)
Pitch gliss
Measurement of the proportion of syllables with large pitch movement (in percents)
Pitch rises
Measurement of the proportion of syllables with pitch rise (in percents)
Pitch falls
Measurement of the proportion of syllables with pitch fall (in percents)
Nuclei duration
Sum of durations for syllable nuclei for the speaker (in seconds)
Internuclei Duration
Sum of durations between successive nuclei for the speaker (in seconds)
Intrasyllabic Trajectory
Pitch trajectory (sum of absolute intervals) within syllabic nuclei, divided by duration (in semitones per second)
Intersyllabic Trajectory
Pitch trajectory (sum of absolute intervals) between syllabic nuclei (except pauses or speaker turns), divided by duration (in semitones per second)
Percentage of turns interviewer
Interviewer's total number of turns divided by the total number of turns of the dialogue (in percents)
Percentage of turns participant
Participant's total number of turns divided by the total number of turns of the dialogue (in percents)
Interviewer's Floor Occupation
Portion of time where only the interviewer is speaking (in percents)
Participant's Floor Occupation
Portion of time where only the participant is speaking (in percents)
Overlap
Portion of time where both interactants are speaking (in percents)
Mutual silence
Portion of time where both interactants are silent (in percents)
Between-Overlap
Turn transition composed of overlapping speech from both interlocutors (in percents)
Gap
Silent interval between turn transitions (in percents)
Within-Overlap
Passages of overlapping speech not followed by a change of speaker (in percents)
Floor Transfer Offset
Measures of gaps (positive values) and overlaps (negative values) in milliseconds
Interviewer's Speaking Turn Duration
Average duration of interviewer's speaking turns in milliseconds
Interviewer's Silent Turn Duration
Average duration of interviewer's pauses in milliseconds
Participant's Speaking Turn Duration
Average duration of the participant's speaking turns in milliseconds
Participant's Silent Turn Duration
Average duration of the participant's pauses in milliseconds
Minimal self
Measure on the Multidimensional Assessment of Interoceptive Awareness - Version 2; Min = 0, max =185; Higher score is a better outcome
Narrative self
Measure on the Tennessee Self Concept Scale - Short Form, Present; Min = 21, max = 105; Higher score is a better outcome
Visual episodic memory performance
Measure on the Family Pictures from Wechsler Memory Scale-III (standardized score)
Current emotional state before the task
Measure on the Mood Visual Analogue Scale; Min = 0, max = 100; Higher score is a better outcome
Embodiment
Measure on the Embodiment Questionnaire; Min = -3, max = 3; Higher score is a better outcome
Presence
Measure on the Igroup Presence Questionnaire; Min = -42, max = 42; Higher score is a better outcome
Cybersickness
Measure on the Simulator Sickness Questionnaire; Min = 0, max = 48; Higher score is a worse outcome
Current emotional state after the task
Measure on the Mood Visual Analogue Scale; Min = 0, max = 100; Higher score is a better outcome
Recognition task: "What" 1
Proportion of hits (number of recognised events divided by total number of events) (in percents)
Recognition task: "What" 2
Proportion of false alarms (number of falsely recognised lures divided by total number of lures) (in percents)
Recognition task: "What" 3
Hit mean reaction time (in seconds)
Recognition task: "What" 4
False alarm mean reaction time (in seconds)
Recognition task: "When"
Proportion of correct "When" answers (number of correct "When" answers divided by number of hits) (in percents)
Recognition task: "Where"
Proportion of correct "Where" answers (in percents)
Recognition task: "Source"
Proportion of correct "Source" answers (in percents)
Recognition task: "Binding What-When-Where"
Mean of (What + When + Where) (in percents)
Recognition task: "Binding What-When-Where-Source"
Mean of (What + When + Where + Source) (in percents)
Recognition task: "Referent"
Proportion of correct "Referent" answers (in percents)
Recognition task: "Remember/Know"
Mean (a score between 0 and 100)
Recognition task: "Perspective"
Mean (a score between 0 and 100)
Recognition task: "Vivacity"
Mean (a score between 0 and 100)
Recognition task: "Fidelity"
Mean (a score between 0 and 100)
Recognition task: "Emotional intensity"
Mean (a score between 0 and 100)
Recognition task: "Strength of associated bodily sensations"
Mean (a score between 0 and 100)
Recognition task: "Episodic self-reference"
Mean (a score between 0 and 100)
Recognition task: "Semantic self-reference"
Mean (a score between 0 and 100)
Free recall: "What"
Proportion of recalled events (in percents)
Free recall: "When"
Proportion of correct "When" answers (in percents)
Free recall: "Where"
Proportion of correct "Where" answers (in percents)
Free recall: "Source"
Proportion of correct "Source" answers (in percents)
Free recall: "Binding What-When-Where"
Mean of (What + When + Where) (in percents)
Free recall: "Binding What-When-Where-Source"
Mean of (What + When + Where + Source) (in percents)
Free recall: "Referent"
Proportion of correct "Referent" answers (in percents)
Free recall: "Objective details"
Mean number of objective details
Free recall: "Subjective details"
Mean number of subjective details
Free recall: "Remember/Know" 1
Proportion of "Remember" answers (in percents)
Free recall: "Remember/Know" 2
Proportion of "Know" answers (in percents)

Full Information

First Posted
July 12, 2021
Last Updated
September 18, 2023
Sponsor
Centre Hospitalier St Anne
Collaborators
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT06045897
Brief Title
EEG Microstates Across At-Risk Mental States
Acronym
DEMETER
Official Title
Determination of EEG Microstates Associated With Mental Disorders in At-Risk States (Détermination Des Microétats EEG associés Aux Troubles Psychiques Dans Les États à Risque - DEMETER)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 30, 2023 (Actual)
Primary Completion Date
July 30, 2026 (Anticipated)
Study Completion Date
July 30, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier St Anne
Collaborators
Assistance Publique - Hôpitaux de Paris

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this observational study is to compare subjects with at-risk-mental-state, early psychosis, schizophrenia, depression, and autism spectrum disorders, with healthy controls (N = 21 x 6). The main questions it aims to answer are: are EEG microstate anomalies associated with diagnosis, clinical and functional prognosis, both in resting conditions and during sleep ? are EEG microstates anomalies associated with differences in sensorimotor integration, prosodic and conversational, interoceptive, and narrative self ? an ancillary study will be to see whether in healthy controls EEG microstate properties vary under light hypnosis conditions. Participants will: undergo deep phenotyping based on psychopathology and neuropsychological assessments undergo a high-resolution EEG (64 electrodes) with a resting period and a sensorimotor task; and healthy controls will have a light hypnosis period. undergo a recording of the characteristics of their voice (tone, prosody) undergo a one-night polysomnography undergo MRI and biological sampling for multi-omic analyses undergo a virtual reality experience
Detailed Description
Aim of the study: EEG microstates translate the resting-state temporal dynamics of neuronal networks throughout the brain. Here, the investigators aim to see whether EEG microstate anomalies could constitute markers of psychiatric disorders. Methods: six groups of 21 participants each will be included. There will be five groups of participants with psychiatric disorders (at-risk-mental state - ARMS, first-episode psychosis - FEP, schizophrenia - SCZ, major depressive disorder - MDD, and autism spectrum disorders - ASD) and one group of healthy controls. Our main objective is to test differences in means between the groups, at rest and during sleep, for each of the variables characterizing each of the microstates (duration, frequency, occupation time) as well as, secondarily, EEG measures of connectivity (somatosensory evoked potentials), cortical excitability (alpha-band power), and prosodic and conversational linguistic measures. Regarding the microstates measures: a five minute eyes-closed resting-state EEG with 64 channels will be recorded (as part of the larger task including the sensorimotor task described below). A minimal preprocessing will be done with the MNE EEG software on Python, which includes a bandpass filter between 0.5 and 40 Hz, rereferencing to the mean, and visual and automatic correction for artifacts. Each recording will be visually reanalyzed by clinical neurophysiologists to ensure it is indeed an alpha-dominant, resting rhythm without any residual artifact. Microstate analysis will be done using the Pycrostates package. Global field power (GFP) will be determined for each participant. Only EEG topographies at GFP peaks will be retained to determine microstates' topographies, through a modified K-means clustering. For each subject the same number of GFP peaks will be extracted and concatenated into a single data set for clustering. A combined score will be used to compute the optimal number of clusters. The resulting clusters will be backfitted to each individual maps. Temporal smoothing will be used to ensure that periods of inter-peak noise, of low GFP, did not interrupt the sequences of quasi-stable segments. For each subject, three parameters will be computed for each microstate class: frequency of occurrence ("occurrence"), temporal coverage ("coverage") and mean duration. Occurrence is the average number of times a given microstate occurs per second. Coverage (in %) is the percentage of total analysis time spent in a given microstate. Mean duration (in ms) is the average time during which a given microstate was present in an uninterrupted manner (after temporal smoothing). Regarding the linguistic measures: each participant undergoes a semi-structured interview with a trained experimenter. Both the participant and the interviewer wear head-set AKG-C544L condenser microphones, connected via AKG MPA VL phantom adaptors to a Zoom H4n Pro Handy recorder. Speech is digitally recorded at a sampling rating of 44000 Hz (16-bit). The distance between the mouth and the microphone is kept as constant as possible (2 cm) to assure consistent levels of vocal loudness. The interviews are done in a quiet room to limit environmental noise; the two interactants are placed as far as possible, to prevent crosstalk (i.e. speech of the interviewer caught by participant's microphone and vice versa). The .wav files obtained from the recordings are annotated using the Praat software and subsequently analysed with Praat and R. Prosodic features are extracted using the Prosogram tool (a set of Praat scripts, open-source) and a new modified version of scripts from the Prosogram tool. Turn-taking variables are extracted with new combined Praat and R scripts. Regarding the sensorimotor intergration measures: the sensorimotor integration is investigated using a visuo-haptic task. On each trial, the participant, seated in front of a screen, has a visual instruction (a point to the right or left of the screen). The task consists of pressing one of the two buttons positioned on each side of the body with the index finger of the corresponding hand according to the visual instruction. A vibrotactile stimulator (small speakers wired to an Arduino electronic card modulated by an amplifier) is applied to the first dorsal interosseous muscle of both hands. 400 msec before the visual instruction, one of the two hands receives a tactile cue (vibration) on one hand for 100 msec. This cue is more or less reliable depending on the block. In some blocks, it is quite reliable, since 90% of the trials present the vibration and visual instruction congruently (indicating the same hand). Another condition is composed of only 50% of the congruent trials, and in this case, the tactile cue is not reliable. Two blocks with 70% congruent cases are carried out intermediately. Finally, a baseline block which does not contain any tactile cues is presented at the beginning and the end of the task. The order of the 90% and 50% blocks is randomized. The tactile and visual stimuli are generated with a MATLAB script. Each block consists of 100 trials, in total 500 trials. Electroencephalographic (EEG) data is recorded throughout the task, using a 64-channel EEG cap (from Biosemi) in order to record the electrical brain activity. The setup is coupled to an eyetracker, to control that the participant is fixating the cross at the center of the screen during each block. Regarding the multidimensional self and episodic memory task (task design: Laboratoire Mémoire, Cerveau et Cognition): at baseline, participants will be submitted to self-reported questionnaires assessing their sense of minimal Self on 8 domains (Multidimensional Assessment of Interoceptive Awareness - Version 2) and sense of narrative Self on 5 domains (Tennessee Self Concept Scale - Short Form, Present). They will undergo a neuropsychological test assessing their visual episodic memory performance (Family Pictures from Wechsler Memory Scale-III). They will rate their current emotional state on a visual analogue scale on 4 domains (Mood Visual Analogue Scale). Following each of the two navigation sessions in virtual reality, which consist in a walk through a virtual city where participants encounter daily life events that aim to be incidentally encoded in episodic memory, associated with different levels of self-reference, participants will be submitted to self-reported questionnaires assessing their sense of embodiment on 4 domains (Embodiment Questionnaire), their sense of presence on 4 domains (Igroup Presence Questionnaire), and their cybersickness on 2 domains (Simulator Sickness Questionnaire). They will rate again their current emotional state on a visual analogue scale (Mood Visual Analogue Scale). Finally, participants will undergo two episodic memory tests: a free recall task and a recognition task. The free recall will be based on a verbal interview of 20 minutes, during which participants will be asked to recall all the events that they remember encountering in the virtual city. For each event, they will be asked to recall systematically and the most precisely possible: what was the event, where and when it happened during the navigation, in which of the two navigation it happened (source), who was the referent according to which the personal significance of the event was assessed, objective (perceptive) and subjective (phenomenological) details of the event, and if the event was vividly relived or felt merely familiar (Remember/Know procedure). The recognition test will be performed on a computer and programmed using the Python module Neuropsydia. All 32 encountered events mixed with 16 lures which were not encountered will be displayed successfully in a random order on a computer screen. For each event, several questions will be asked successfully and participants will click on what they consider the correct answer among several propositions: did they encounter the event (Yes/No), and if yes where it happened (among several possible localisations on a picture of the zone where the event occurred), when it happened (replacing the event in the chronological order with two other events), in which navigation (first or second navigation), and who was the referent (Me/Other). For each event, participants will also rate on scales ranging from 0 to 100: the degree of reliving or familiarity of the event (100 = Remember, 0 = Know), the perspective of the memory (100 = first-person perspective, 0 = third-person perspective), its vivacity, fidelity, emotional intensity, strength of associated bodily sensations, episodic self-reference, and semantic self-reference. For all variables, the investigators will apply a repeated measures ANOVA, and use the following contrasts: "ARMS, FEP, SCZ, ASD, MDD" vs. "Healthy subjects" (microstates are tested as markers of general psychopathology); "ARMS, FEP, SCZ" vs "ASD, MDD" (microstates are tested as specific markers of psychosis; equivalently, the specificity of this signature for depression and ASD will be tested) "ARMS" vs. "FEP" vs. "SCZ" (microstates are tested as evolutionary markers); Finally, depending on the rate of transition to psychosis among UHRs, a comparison of "UHR-T" vs "UHR-NT" can be made (microstates are tested as predictive markers of psychosis All subjects will undergo a deep phenotyping including neuropsychology, psychopathology, neurological soft signs scales, as well as structural MRI, and genetic and epigenetic measures. Hypothesis: imbalances in EEG microstates C and D are expected to be more pronounced across the spectrum of psychosis and in ASD compared to controls, MDD, and ARMS, and be associated with anomalies in somatosensory, interoceptive, and language characteristics.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychotic Disorders, Autism Spectrum Disorder, Major Depressive Disorder, Schizophrenia
Keywords
electroencephalography, at risk mental state, ultra high risk, first episode psychosis, schizophrenia, autism spectrum disorder, EEG microstates, polysomnography, sensorimotor integration, prosody, hypnosis

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
126 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Major depressive disorder
Arm Type
Experimental
Arm Description
Major depressive disorder as defined by DSM-5 classification
Arm Title
Autism spectrum disorder
Arm Type
Experimental
Arm Description
Autism spectrum disorder as defined by DSM-5 classification
Arm Title
At risk mental state
Arm Type
Experimental
Arm Description
At risk mental state as defined in the CAARMS
Arm Title
First episode psychosis
Arm Type
Experimental
Arm Description
Any DSM-5 category associated with psychotic symptoms
Arm Title
Schizophrenia
Arm Type
Experimental
Arm Description
Schizophrenia as defined by DSM-5 classification
Arm Title
Healthy controls
Arm Type
Experimental
Arm Description
Healthy controls with no history of neurodevelopmental disorder or psychotic disorder in a first degree relative
Intervention Type
Device
Intervention Name(s)
EEG 64 channels
Intervention Description
64-channel EEG in wake and resting conditions for 1h30, with oculogram, electromyogram and electromyogram and electrocardiogram. Five minutes of eyes closed will be used for microstate analysis. 1h30 will be used for the sensorimotor task.
Intervention Type
Device
Intervention Name(s)
Polysomnography 19 electrodes
Intervention Description
Overnight polysomnography with 19 EEG channels and ventilatory polygraphy.
Intervention Type
Behavioral
Intervention Name(s)
Light hypnosis
Intervention Description
Healthy controls will undergo a 5 min light hypnosis exercise that will be focused on proprioception.
Intervention Type
Biological
Intervention Name(s)
Biological sampling
Intervention Description
Blood samples will be taken for genetic, epigenetic, proteomic, and metabolomic studies.
Intervention Type
Behavioral
Intervention Name(s)
Virtual reality
Intervention Description
Participants will undergo a virtual reality task using a head-mounted display, and their multidimensional self will be assessed prior to and after the task via the self-reference effect on episodic memory.
Intervention Type
Device
Intervention Name(s)
Voice recording
Intervention Description
A double channel audio recorder will be used during 30 min to assess voice characteristics of all subjects.
Primary Outcome Measure Information:
Title
Occurrence of EEG microstates
Description
Average number of times a given microstate occurs per second.
Time Frame
Three years
Title
Coverage of EEG microstates
Description
Percentage of total analysis time spent in a given microstate.
Time Frame
Three years
Title
Mean duration of EEG microstates
Description
Average time during which a given microstate was present in an uninterrupted manner (after temporal smoothing).
Time Frame
Three years
Secondary Outcome Measure Information:
Title
Attention modulation
Description
Measurement of alpha band power (in Hz)
Time Frame
Three years
Title
Cortical excitability and inhibition
Description
Measurement of mu and theta bands (in Hz)
Time Frame
Three years
Title
Integration of sensory information: amplitudes
Description
Measurement of amplitudes (in µV) of somatosensory evoked potentials
Time Frame
Three years
Title
Integration of sensory information: latencies
Description
Measurement of latencies (in msec) of somatosensory evoked potentials
Time Frame
Three years
Title
Reaction time
Description
The adaptation of the reaction time (in msec) to the button press according to the probabilistic context of congruency is examined.
Time Frame
Three years
Title
Speech rate
Description
Measurement of number of syllables/sec in the recording of the subjects
Time Frame
Three years
Title
Fundamental frequency
Description
Measurement of the fundamental frequency (in Hz)
Time Frame
Three years
Title
Pitch mean
Description
Measurement of the pitch mean (in semi-tones)
Time Frame
Three years
Title
Pitch range
Description
Measurement of the pitch range (in semi-tones)
Time Frame
Three years
Title
Pitch gliss
Description
Measurement of the proportion of syllables with large pitch movement (in percents)
Time Frame
Three years
Title
Pitch rises
Description
Measurement of the proportion of syllables with pitch rise (in percents)
Time Frame
Three years
Title
Pitch falls
Description
Measurement of the proportion of syllables with pitch fall (in percents)
Time Frame
Three years
Title
Nuclei duration
Description
Sum of durations for syllable nuclei for the speaker (in seconds)
Time Frame
Three years
Title
Internuclei Duration
Description
Sum of durations between successive nuclei for the speaker (in seconds)
Time Frame
Three years
Title
Intrasyllabic Trajectory
Description
Pitch trajectory (sum of absolute intervals) within syllabic nuclei, divided by duration (in semitones per second)
Time Frame
Three years
Title
Intersyllabic Trajectory
Description
Pitch trajectory (sum of absolute intervals) between syllabic nuclei (except pauses or speaker turns), divided by duration (in semitones per second)
Time Frame
Three years
Title
Percentage of turns interviewer
Description
Interviewer's total number of turns divided by the total number of turns of the dialogue (in percents)
Time Frame
Three years
Title
Percentage of turns participant
Description
Participant's total number of turns divided by the total number of turns of the dialogue (in percents)
Time Frame
Three years
Title
Interviewer's Floor Occupation
Description
Portion of time where only the interviewer is speaking (in percents)
Time Frame
Three years
Title
Participant's Floor Occupation
Description
Portion of time where only the participant is speaking (in percents)
Time Frame
Three years
Title
Overlap
Description
Portion of time where both interactants are speaking (in percents)
Time Frame
Three years
Title
Mutual silence
Description
Portion of time where both interactants are silent (in percents)
Time Frame
Three years
Title
Between-Overlap
Description
Turn transition composed of overlapping speech from both interlocutors (in percents)
Time Frame
Three years
Title
Gap
Description
Silent interval between turn transitions (in percents)
Time Frame
Three years
Title
Within-Overlap
Description
Passages of overlapping speech not followed by a change of speaker (in percents)
Time Frame
Three years
Title
Floor Transfer Offset
Description
Measures of gaps (positive values) and overlaps (negative values) in milliseconds
Time Frame
Three years
Title
Interviewer's Speaking Turn Duration
Description
Average duration of interviewer's speaking turns in milliseconds
Time Frame
Three years
Title
Interviewer's Silent Turn Duration
Description
Average duration of interviewer's pauses in milliseconds
Time Frame
Three years
Title
Participant's Speaking Turn Duration
Description
Average duration of the participant's speaking turns in milliseconds
Time Frame
Three years
Title
Participant's Silent Turn Duration
Description
Average duration of the participant's pauses in milliseconds
Time Frame
Three years
Title
Minimal self
Description
Measure on the Multidimensional Assessment of Interoceptive Awareness - Version 2; Min = 0, max =185; Higher score is a better outcome
Time Frame
Three years
Title
Narrative self
Description
Measure on the Tennessee Self Concept Scale - Short Form, Present; Min = 21, max = 105; Higher score is a better outcome
Time Frame
Three years
Title
Visual episodic memory performance
Description
Measure on the Family Pictures from Wechsler Memory Scale-III (standardized score)
Time Frame
Three years
Title
Current emotional state before the task
Description
Measure on the Mood Visual Analogue Scale; Min = 0, max = 100; Higher score is a better outcome
Time Frame
Three years
Title
Embodiment
Description
Measure on the Embodiment Questionnaire; Min = -3, max = 3; Higher score is a better outcome
Time Frame
Three years
Title
Presence
Description
Measure on the Igroup Presence Questionnaire; Min = -42, max = 42; Higher score is a better outcome
Time Frame
Three years
Title
Cybersickness
Description
Measure on the Simulator Sickness Questionnaire; Min = 0, max = 48; Higher score is a worse outcome
Time Frame
Three years
Title
Current emotional state after the task
Description
Measure on the Mood Visual Analogue Scale; Min = 0, max = 100; Higher score is a better outcome
Time Frame
Three years
Title
Recognition task: "What" 1
Description
Proportion of hits (number of recognised events divided by total number of events) (in percents)
Time Frame
Three years
Title
Recognition task: "What" 2
Description
Proportion of false alarms (number of falsely recognised lures divided by total number of lures) (in percents)
Time Frame
Three years
Title
Recognition task: "What" 3
Description
Hit mean reaction time (in seconds)
Time Frame
Three years
Title
Recognition task: "What" 4
Description
False alarm mean reaction time (in seconds)
Time Frame
Three years
Title
Recognition task: "When"
Description
Proportion of correct "When" answers (number of correct "When" answers divided by number of hits) (in percents)
Time Frame
Three years
Title
Recognition task: "Where"
Description
Proportion of correct "Where" answers (in percents)
Time Frame
Three years
Title
Recognition task: "Source"
Description
Proportion of correct "Source" answers (in percents)
Time Frame
Three years
Title
Recognition task: "Binding What-When-Where"
Description
Mean of (What + When + Where) (in percents)
Time Frame
Three years
Title
Recognition task: "Binding What-When-Where-Source"
Description
Mean of (What + When + Where + Source) (in percents)
Time Frame
Three years
Title
Recognition task: "Referent"
Description
Proportion of correct "Referent" answers (in percents)
Time Frame
Three years
Title
Recognition task: "Remember/Know"
Description
Mean (a score between 0 and 100)
Time Frame
Three years
Title
Recognition task: "Perspective"
Description
Mean (a score between 0 and 100)
Time Frame
Three years
Title
Recognition task: "Vivacity"
Description
Mean (a score between 0 and 100)
Time Frame
Three years
Title
Recognition task: "Fidelity"
Description
Mean (a score between 0 and 100)
Time Frame
Three years
Title
Recognition task: "Emotional intensity"
Description
Mean (a score between 0 and 100)
Time Frame
Three years
Title
Recognition task: "Strength of associated bodily sensations"
Description
Mean (a score between 0 and 100)
Time Frame
Three years
Title
Recognition task: "Episodic self-reference"
Description
Mean (a score between 0 and 100)
Time Frame
Three years
Title
Recognition task: "Semantic self-reference"
Description
Mean (a score between 0 and 100)
Time Frame
Three years
Title
Free recall: "What"
Description
Proportion of recalled events (in percents)
Time Frame
Three years
Title
Free recall: "When"
Description
Proportion of correct "When" answers (in percents)
Time Frame
Three years
Title
Free recall: "Where"
Description
Proportion of correct "Where" answers (in percents)
Time Frame
Three years
Title
Free recall: "Source"
Description
Proportion of correct "Source" answers (in percents)
Time Frame
Three years
Title
Free recall: "Binding What-When-Where"
Description
Mean of (What + When + Where) (in percents)
Time Frame
Three years
Title
Free recall: "Binding What-When-Where-Source"
Description
Mean of (What + When + Where + Source) (in percents)
Time Frame
Three years
Title
Free recall: "Referent"
Description
Proportion of correct "Referent" answers (in percents)
Time Frame
Three years
Title
Free recall: "Objective details"
Description
Mean number of objective details
Time Frame
Three years
Title
Free recall: "Subjective details"
Description
Mean number of subjective details
Time Frame
Three years
Title
Free recall: "Remember/Know" 1
Description
Proportion of "Remember" answers (in percents)
Time Frame
Three years
Title
Free recall: "Remember/Know" 2
Description
Proportion of "Know" answers (in percents)
Time Frame
Three years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age between 15 and 30 years subjects meeting CAARMS criteria for stage Ia or Ib mental states at risk (for stage Ia, mild or nonspecific symptoms of psychosis or severe mood disorder, and mild functional impairment; for stage Ib, moderate symptoms below intervention threshold and moderate functional impairment) subjects meeting any DSM-5 criteria associated with a first onset of psychotic symptoms (first episode psychosis) subjects satisfying DSM-5 criteria for depressive disorder subjects meeting DSM-5 criteria for autism spectrum disorder healthy control subjects recruited from the general population Exclusion Criteria: suicidal risk severe or non-stabilized somatic and neurological disorders epilepsy head trauma IQ below 70 for healthy control subjects, a family history of psychosis is an exclusion criterion bipolar disorder obsessive-compulsive disorder substance use disorder, except for cannabis, tolerated up to 5 joints/day.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anton Iftimovici, MD, PhD
Phone
0033(0)145658179
Email
anton.iftimovici@ghu-paris.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Valeria Lucarini, MD, MS
Phone
0033(0)145658179
Email
valeria.lucarini@ghu-paris.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anton Iftimovici, MD, PhD
Organizational Affiliation
GHU Paris Psychiatrie et Neurosciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre de Recherche Clinique, Hôpital Sainte-Anne, GHU Paris Psychiatrie et Neurosciences
City
Paris
ZIP/Postal Code
75014
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bénédicte Coutard
Phone
0033(0)145656250
Email
b.coutard@ghu-paris.fr
First Name & Middle Initial & Last Name & Degree
Anton Iftimovici, MD, PhD
First Name & Middle Initial & Last Name & Degree
Valeria Lucarini, MD, MS
First Name & Middle Initial & Last Name & Degree
Anaelle Alouit, MS
First Name & Middle Initial & Last Name & Degree
Delphine Yeh, MS

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
37246142
Citation
Iftimovici A, Marchi A, Ferat V, Pruvost-Robieux E, Guinard E, Morin V, Elandaloussi Y, D'Halluin A, Krebs MO, Chaumette B, Gavaret M. Electroencephalography microstates imbalance across the spectrum of early psychosis, autism, and mood disorders. Eur Psychiatry. 2023 May 29;66(1):e41. doi: 10.1192/j.eurpsy.2023.2414.
Results Reference
background
PubMed Identifier
36907708
Citation
Gavaret M, Iftimovici A, Pruvost-Robieux E. EEG: Current relevance and promising quantitative analyses. Rev Neurol (Paris). 2023 Apr;179(4):352-360. doi: 10.1016/j.neurol.2022.12.008. Epub 2023 Mar 10.
Results Reference
background

Learn more about this trial

EEG Microstates Across At-Risk Mental States

We'll reach out to this number within 24 hrs